- Home
- ADN vs SYRS Comparison
ADN vs SYRS Comparison
Compare ADN & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADN
- SYRS
- Stock Information
- Founded
- ADN 2006
- SYRS 2011
- Country
- ADN United States
- SYRS United States
- Employees
- ADN N/A
- SYRS N/A
- Industry
- ADN Power Generation
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- ADN Utilities
- SYRS Health Care
- Exchange
- ADN Nasdaq
- SYRS Nasdaq
- Market Cap
- ADN 8.5M
- SYRS 7.1M
- IPO Year
- ADN N/A
- SYRS 2016
- Fundamental
- Price
- ADN $5.00
- SYRS $0.21
- Analyst Decision
- ADN
- SYRS Hold
- Analyst Count
- ADN 0
- SYRS 5
- Target Price
- ADN N/A
- SYRS $3.00
- AVG Volume (30 Days)
- ADN 62.8K
- SYRS 3.5M
- Earning Date
- ADN 10-15-2024
- SYRS 10-31-2024
- Dividend Yield
- ADN N/A
- SYRS N/A
- EPS Growth
- ADN N/A
- SYRS N/A
- EPS
- ADN N/A
- SYRS N/A
- Revenue
- ADN $7,026,000.00
- SYRS $386,000.00
- Revenue This Year
- ADN $2,232.99
- SYRS N/A
- Revenue Next Year
- ADN $91.56
- SYRS $1,011.11
- P/E Ratio
- ADN N/A
- SYRS N/A
- Revenue Growth
- ADN 9.01
- SYRS N/A
- 52 Week Low
- ADN $1.71
- SYRS $0.18
- 52 Week High
- ADN $10.11
- SYRS $8.17
- Technical
- Relative Strength Index (RSI)
- ADN 45.74
- SYRS 29.09
- Support Level
- ADN $5.79
- SYRS $0.20
- Resistance Level
- ADN $6.77
- SYRS $0.26
- Average True Range (ATR)
- ADN 0.64
- SYRS 0.02
- MACD
- ADN -0.17
- SYRS 0.07
- Stochastic Oscillator
- ADN 34.44
- SYRS 11.39
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.